Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults is a research paper published in JAMA (2022). On theSindex it has a DataRank of 0.948. It has been cited 555 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.948
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →FWCI
49.01
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Clinical spectrum and prognostic impact of cancer in critically ill patients with HIV: a multicentre cohort study
Additional file 1 of Clinical spectrum and prognostic impact of cancer in critically ill patients with HIV: a multicentre cohort study
Additional file 1 of Clinical spectrum and prognostic impact of cancer in critically ill patients with HIV: a multicentre cohort study
Additional file 1 of Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies
Additional file 1 of Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies
Additional file 2 of Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies
Additional file 2 of Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies
Additional file 1 of Identification of a circulating long non-coding RNA signature panel in plasma as a novel biomarker for the detection of acute/early-stage HIV-1 infection
Additional file 1 of Identification of a circulating long non-coding RNA signature panel in plasma as a novel biomarker for the detection of acute/early-stage HIV-1 infection
Additional file 1 of Low-level HIV-1 viremia affects T-cell activation and senescence in long-term treated adults in the INSTI era
Additional file 1 of Low-level HIV-1 viremia affects T-cell activation and senescence in long-term treated adults in the INSTI era